Evidence map›Paper›PMID 32046815›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2020

Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020.

Chantal B E M Reusken, Eeva K Broberg, Bart Haagmans, Adam Meijer, Victor M Corman, Anna Papa, Remi Charrel, Christian Drosten, Marion Koopmans, Katrin Leitmeyer and 1 more

Registry-linked trialAbstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04913701 (Observational Study for SARS-Cov2 Epidemiological Surveillance on Healthcare Workers and Patients in a Rehabilitation Medicine Facility), which is not on this map. Cited by 95 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04913701 completednot on this map

Observational Study for SARS-Cov2 Epidemiological Surveillance on Healthcare Workers and Patients in a Rehabilitation Medicine Facility

TypeobservationalSponsorIRCCS San Raffaele RomaRan2020 to 2020Enrolled500ConditionsSARS-Cov2ArmsObservation group 1
3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Prospective, clinical comparison of self-collected throat-bilateral nares swabs and saline gargle compared to health care provider collected nasopharyngeal swabs among symptomatic outpatients with potential SARS-CoV-2 infection.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Molecular diagnostics of SARS-CoV-2: Findings of an international survey.Clinica chimica acta; international journal of clinical chemistry · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Enfermedades infecciosas y microbiologia clinica · 2022
    Article
  19. Article
  20. Performance verification of five commercial RT-qPCR diagnostic kits for SARS-CoV-2.Clinica chimica acta; international journal of clinical chemistry · 2022
    Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Chantal B E M ReuskenCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Eeva K BrobergEuropean Centre for Disease Prevention and Control, Solna, Sweden.
Bart HaagmansViroscience department, Erasmus MC, Rotterdam, the Netherlands.
Adam MeijerCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Victor M CormanCharité - Universitätsmedizin Berlin Institute of Virology, Berlin, Germany.
Anna PapaDepartment of Microbiology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Remi CharrelUnité des Virus Emergents (Aix-Marseille Univ-IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France.
Christian DrostenCharité - Universitätsmedizin Berlin Institute of Virology, Berlin, Germany.
Marion KoopmansViroscience department, Erasmus MC, Rotterdam, the Netherlands.
Katrin LeitmeyerEuropean Centre for Disease Prevention and Control, Solna, Sweden.
EVD-LabNet and ERLI-NetThe participating members of EVD-LabNet and ERLI-Net are acknowledged at the end of the article.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Timely detection of novel coronavirus (2019-nCoV) infection cases is crucial to interrupt the spread of this virus. We assessed the required expertise and capacity for molecular detection of 2019-nCoV in specialised laboratories in 30 European Union/European Economic Area (EU/EEA) countries. Thirty-eight laboratories in 24 EU/EEA countries had diagnostic tests available by 29 January 2020. A coverage of all EU/EEA countries was expected by mid-February. Availability of primers/probes, positive controls and personnel were main implementation barriers.

Indexed as

BetacoronavirusClinical Laboratory TechniquesCoronavirusCoronavirus InfectionsCOVID-19Disease OutbreaksEuropean UnionHumansLaboratoriesPneumonia, ViralReference StandardsReverse Transcriptase Polymerase Chain ReactionRNA, ViralSARS-CoV-2Sensitivity and SpecificitySentinel SurveillanceRNA, Viral2019-nCoVcoronavirusemerging infectionslaboratoryresponsezoonoses

Identifiers

PMID32046815
PMCPMC7029448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.